{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:15:03Z","timestamp":1788110103144,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education","doi-asserted-by":"crossref","award":["20130182110023"],"award-info":[{"award-number":["20130182110023"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"name":"high-end engineering and technical personnel training plan of Chongqing","award":["2013-2016"],"award-info":[{"award-number":["2013-2016"]}]},{"name":"Major Program of Chongqing Educational Commission","award":["KJZH14203"],"award-info":[{"award-number":["KJZH14203"]}]},{"name":"County-University cooperation Innovation funds of Southwest University","award":["Sz201501"],"award-info":[{"award-number":["Sz201501"]}]},{"name":"County-University cooperation Innovation funds of Southwest University","award":["Sz201401"],"award-info":[{"award-number":["Sz201401"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.lfs.2016.02.046","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T18:08:18Z","timestamp":1455386898000},"page":"50-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters"],"prefix":"10.1016","volume":"151","author":[{"given":"Shuming","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.02.046_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1078\/094471103321648610","article-title":"The effects of coptidis rhizoma extract on a hypercholesterolemic animal model","volume":"10","author":"Yokozawa","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2016.02.046_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(13)61910-8","article-title":"Running interference to lower cholesterol","volume":"383","author":"Burnett","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.02.046_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2005.03.033","article-title":"Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing","volume":"184","author":"Li","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2016.02.046_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2014.07.048","article-title":"Mechanism of action of anti-hypercholesterolemia drugs and their resistance","volume":"741","author":"Tiwari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"Arsenault","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0030","article-title":"The regulation of alfalfa saponin extract on key genes involved in hepatic cholesterol metabolism in hyperlipidemic rats","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.02.046_bb0035","first-page":"136","article-title":"Modulation of regulatory factors involved in cholesterol metabolism in response to feeding of pravastatin- or cholesterol-supplemented diet in chickens","volume":"2005","author":"Matsuyama","year":"1734","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2016.02.046_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0922-4106(95)90143-4","article-title":"Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation","volume":"291","author":"Vigano","year":"1995","journal-title":"Eur. J. Pharm-Molec. Ph."},{"key":"10.1016\/j.lfs.2016.02.046_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tcm.2009.10.003","article-title":"The role of HMGCR alternative splicing in statin efficacy","volume":"19","author":"Medina","year":"2009","journal-title":"Trends Cardiovas. Med."},{"key":"10.1016\/j.lfs.2016.02.046_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.02.046_bb0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1445-5994.2011.02622.x","article-title":"Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people","volume":"42","author":"Haerer","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.lfs.2016.02.046_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jfma.2013.05.016","article-title":"Are statins really wonder drugs?","volume":"113","author":"Grover","year":"2014","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"key":"10.1016\/j.lfs.2016.02.046_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11584380-000000000-00000","article-title":"Clinical implications of pharmacogenetic variation on the effects of statins","volume":"34","author":"Maggo","year":"2011","journal-title":"Drug Saf."},{"key":"10.1016\/j.lfs.2016.02.046_bb0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2016.02.046_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High-density lipoprotein as a protective factor against coronary heart-disease - Framingham study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lfs.2016.02.046_bb0085","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2016.02.046_bb0090","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bmcl.2006.12.085","article-title":"Antiviral activity of berberine and related compounds against human cytomegalovirus","volume":"17","author":"Hayashi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.046_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","article-title":"The anti-inflammatory potential of berberine in vitro and in vivo","volume":"203","author":"Kuo","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2016.02.046_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.fitote.2011.09.014","article-title":"Cytotoxicity and antihyperglycemic effect of minor constituents from rhizoma coptis in HepG2 cells","volume":"83","author":"Chen","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.lfs.2016.02.046_bb0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jep.2012.10.062","article-title":"Safety evaluation of main alkaloids from Rhizoma Coptidis","volume":"145","author":"Yi","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0110","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.phymed.2014.05.002","article-title":"The antihypercholesterolemic effect of jatrorrhizine isolated from Rhizoma Coptidis","volume":"21","author":"Wu","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2016.02.046_bb0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2016.02.046_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11745-014-3983-7","article-title":"The safety and anti-hypercholesterolemic effect of coptisine in Syrian golden hamsters","volume":"50","author":"He","year":"2015","journal-title":"Lipids"},{"key":"10.1016\/j.lfs.2016.02.046_bb0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ptr.5295","article-title":"Hypolipidemic effect and mechanism of palmatine from coptis chinensis in hamsters fed high-fat diet","volume":"29","author":"Ning","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2016.02.046_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2014.09.026","article-title":"Combination therapy in dyslipidemia: where are we now?","volume":"237","author":"Catapano","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2016.02.046_bb0135","first-page":"319","article-title":"Chromatographic fingerprint analysis of herbal medicines","volume":"3","author":"Wagner","year":"2011","journal-title":"Chinese Herbal Medicines"},{"key":"10.1016\/j.lfs.2016.02.046_bb0140","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbrc.2005.09.195","article-title":"Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase","volume":"338","author":"Hwang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.02.046_bb0145","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1158042","article-title":"Regulation of hepatic lipogenesis by the transcription factor XBP1","volume":"320","author":"Lee","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.lfs.2016.02.046_bb0150","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1021\/jf802607x","article-title":"Gossypin up-regulates LDL receptor through activation of ERK pathway: a signaling mechanism for the hypocholesterolemic effect","volume":"56","author":"Lu","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2016.02.046_bb0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lfs.2016.02.046_bb0160","first-page":"487","article-title":"Report on cardiovascular diseases in China 2013","volume":"29","author":"Chen","year":"2014","journal-title":"Chinese Circulation Journal"},{"key":"10.1016\/j.lfs.2016.02.046_bb0165","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)14234-1","article-title":"Dyslipidaemia","volume":"362","author":"Durrington","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.02.046_bb0170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.phymed.2012.03.011","article-title":"Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats","volume":"19","author":"Cao","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2016.02.046_bb0175","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2014.05.013","article-title":"Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption","volume":"63","author":"Wang","year":"2014","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.lfs.2016.02.046_bb0180","doi-asserted-by":"crossref","first-page":"44k","DOI":"10.1016\/S0002-9149(02)02969-7","article-title":"Use of combination therapy for dyslipidemia: a lipid clinic approach","volume":"90","author":"Brown","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vph.2014.11.002","article-title":"Safety and efficacy of fibrate-statin combination therapy compared to fibrate monotherapy in patients with dyslipidemia: a meta-analysis","volume":"65\u201366","author":"Choi","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.04.121","article-title":"Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: a population-based dynamic cohort study","volume":"190","author":"Chang","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2016.02.046_bb0195","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nutres.2013.04.006","article-title":"Cooked rice prevents hyperlipidemia in hamsters fed a high-fat\/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism","volume":"33","author":"Choi","year":"2013","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2016.02.046_bb0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.foodchem.2010.05.106","article-title":"Effect of high-fat diets supplemented with okara soybean by-product on lipid profiles of plasma, liver and faeces in Syrian hamsters","volume":"124","author":"Villanueva","year":"2011","journal-title":"Food Chem."},{"key":"10.1016\/j.lfs.2016.02.046_bb0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-511X-9-135","article-title":"Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells","volume":"9","author":"Notarnicola","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2016.02.046_bb0210","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1074\/jbc.275.15.10918","article-title":"Farnesoid X receptor responds to bile acids and represses cholesterol 7 alpha-hydroxylase gene (CYP7A1) transcription","volume":"275","author":"Chiang","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:08:56Z","timestamp":1589634536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516300959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":42,"alternative-id":["S0024320516300959"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.046","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}